Local Government Agencies
Illustrating HIV/AIDS in the United States, 2015 Update
HepVu Annual Launch 2025 Toolkit
This toolkit delivers updated data visualizations, infographics, and social media assets spotlighting the intersection of viral hepatitis and the opioid crisis—highlighting regional opioid prescribing rates alongside Hepatitis C mortality trends to support awareness campaigns during Hepatitis Awareness Month.
Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV
This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.
Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States
This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).
Alternative Funding Programs Issue Brief (AFPs). AIDS Drug Assistance Program Benefits Management.
This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.
AIDS Drug Assistance Program Benefits Management Toolkit
This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.
HRSA/CDC Integrated HIV Prevention & Care Plan Guidance Recipient Training
In this webinar, CDC and HRSA speakers review the calendar year 2027–2031 Integrated HIV Prevention & Care Plan Guidance—highlighting key updates, submission requirements, and real-world recipient examples. The training equips CDC- and HRSA-funded jurisdictions with technical support, planning tools, and strategies to develop coordinated HIV prevention and care efforts by the June 30, 2026 deadline.
The Role of Housing in Improving Health Outcomes and HIV Care Continuity for People Who Use Drugs: Narratives and Recommendations from Lived Experience
Completed with support from SAMHSA and the Opioid Response Network, this document presents first-hand narratives, research, and recommendations to understand and explore housing provision as a comprehensive health and overdose prevention strategy. The resource can be used as a series of topic-specific guidance documents or as an overview of person-centered approaches to housing, drug user health, and HIV care.
Webinar: Practical Applications of Mixed Methods for Public Health Program Evaluations
RAISE and NASTAD’s webinar, “Practical Applications of Mixed Methods for Public Health Program Evaluations” took place on Monday, August 5th, 2024. The webinar features a didactic lecture on mixed methods by Dr. Arianna Means and three case studies presented by health department HIV & STI evaluators.